Simultaneous minimally invasive operations in patients with obesity and metabolic syndrome

Abstract

Annotation. This study presented and evaluated the safety of simultaneous minimally invasive intervention in the treatment of patients with obesity and metabolic syndrome in combination with a related surgical disease. The study included the results obtained in the surgical treatment of 194 patients aged from 18 to 60 years, with Obesity I-III, metabolic syndrome, 46 of them had a concomitant surgical disease (gallstone disease or hiatal hernia). 148 patients in I group (control) underwent only isolated metabolic surgery (MS) (laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass). 46 patients in the II group (main) underwent simultaneous surgical intervention (MS + laparoscopic cholecystectomy or MO + cruroplasty). The following indicators were evaluated: age, sex, body mass index (BMI), degree of anesthesiological risks (ASA), duration of inpatient treatment, level of pain according to the Analogue Chromatic Continuous Scale (ACCS) at 12 and 24 hours after surgery. The level of early postoperative complications (postoperative nausea and vomiting, bleeding, infection of p/o wounds). According to the obtained results, the implementation of a simultaneous approach in the process of surgical treatment of bariatric patients with anesthetic risk ASA I-III is safe and allows to achieve a comparable level of postoperative complications, postoperative pain, length of hospital stay, and patients' readiness for discharge compared to isolated bariatric surgery.